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Abstract
Background
Walking limitation in patients with peripheral arterial disease (PAD) and intermittent claudi-
cation (IC) contributes to poorer disease outcomes. Identifying and examining barriers to
walking may be an important step in developing a comprehensive patient-centered self-
management intervention to promote walking in this population.
Aim
To systematically review the literature regarding barriers and enablers to walking exercise in
individuals with IC.
Methods
A systematic review was conducted utilizing integrative review methodology. Five electronic
databases and the reference lists of relevant studies were searched. Findings were catego-
rized into personal, walking activity related, and environmental barriers and enablers using a
social cognitive framework.
Results
Eighteen studies including quantitative (n = 12), qualitative (n = 5), and mixed method (n = 1)
designs, and reporting data from a total of 4376 patients with IC, were included in the review.
The most frequently reported barriers to engaging in walking were comorbid health concerns,
walking induced pain, lack of knowledge (e.g. about the disease pathology and walking rec-
ommendations), and poor walking capacity. The most frequently reported enablers were cog-
nitive coping strategies, good support systems, and receiving specific instructions to walk.
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Findings suggest additionally that wider behavioral and environmental obstacles should be
addressed in a patient-centered self-management intervention.
Conclusions
This review has identified multidimensional factors influencing walking in patients with IC.
Within the social cognitive framework, these factors fall within patient level factors (e.g.
comorbid health concerns), walking related factors (e.g. claudication pain), and environmen-
tal factors (e.g. support systems). These factors are worth considering when developing
self-management interventions to increase walking in patients with IC. Systematic review
registration CRD42018070418.
Introduction
Intermittent claudication(IC), defined as exertional leg pain which goes away with rest, is a
common symptom in patients with peripheral arterial disease (PAD). IC in patients with PAD
reduces walking capacity, quality of life and is associated with increased cardiovascular risk
[1,2]. Individuals with IC have less than half the maximal walking capacity [3], and up to 3–4
time increased risk of mortality compared with their age matched control[4]. Management of
the condition aims to improve longer-term cardiovascular outcomes through risk factor modi-
fication while reducing claudication symptoms, with conservative management being the first
to be considered[5,6]. Walking exercise is the most effective conservative management for
reducing leg symptoms[7], and a supervised exercise program (SEP)[5,8–10] or a home-based
exercise program (HEP) is recommended[11].The rationale for recommending walking exer-
cise in IC includes both the benefit of symptom relief and cardiovascular risk management
[10,12–14]. For patients with IC symptoms to gain these benefits, walking beyond the point of
pain is recommended[5][11], representing a potential barrier to uptake and adherence to the
therapeutic recommendation.
Efforts to engage individuals with IC in therapeutic walking exercise have been challenging
on several fronts. For instance, SEPs for patients with IC experience difficulty with patient
engagement and high levels of attrition[15]. Even when patients successfully complete a SEP,
there are barriers of translating and sustaining the walking ability gained in the clinic to walk-
ing behavior in the free-living environment[16,17]. Similarly, demonstrating the benefits and
economic viability of home-based walking exercise in patients with PAD and IC has been chal-
lenging due to patient attrition, non-adherence and other issues related to barriers to home-
based walking exercise[18]. McDermott et al reported that factors related to walking in
patients with PAD go beyond the barrier of claudication pain[19], underscoring that complex
multi-level factors influence whether or not patients take up, and adhere to, therapeutic walk-
ing exercise recommendations. To improve the participation of individuals with IC in walking
exercise, it is important to understand the reasons why they do not engage in walking exercise
and the enablers that could be useful to develop walking intervention in this population. This
supports the growing interest in self-management approach in treating patients with IC.
Within the conceptual framework of self-management interventions, evidence indicates
that the inclusion of behavior-change techniques contribute to the improvement of pain
free walking ability, self-reported walking ability and daily walking activity in individuals
with IC[20–22]. Several important behavioral change techniques such as barrier identifica-
tion with problem-solving[20,23], self-monitoring[21,23], feedback on performance[21,23],
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goal setting[20,23], social support[23], action planning[20], and structured patients educa-
tion[24] have been highlighted. However, to develop targeted evidence-based self-manage-
ment interventions informed by behavioral change strategies, a clear understating of the
multifactorial barriers and enablers common to IC patients’ participation in walking exer-
cise is required. Identification of these factors via a systematic review, perhaps using a con-
ceptual framework, may be the first step to guide the development of a suitable patient-
centered walking intervention.
One previous review[25] has been conducted to provide generic understanding of barriers
and facilitators to walking in PAD. PAD is an overarching construct and includes a range of
symptom severity from asymptomatic to severe critical limb ischemia with ulceration and gan-
grene. Therefore, barriers to walking may be unique to each stage of the disease. However, the
previous review included patients at different stages of the disease pathway making it impossi-
ble to understand what factors were specific to patients with IC. Similarly, only literature pub-
lished between 2010 and 2016 was included in the previous review. Finally, the previous
review conclusion was limited to older adults (65years) with PAD. Although age is a signifi-
cant risk factor in PAD, young adults are increasingly affected[26,27]. Moreover, age-mediated
variations in the clinical symptomology of PAD suggest that claudication is more prevalent in
the younger patients (50years)[28]. The aim of this review is to systematically review the lit-
erature regarding both self-report and objective measures of barriers and enablers to walking
exercise in individuals with IC.
Materials and methods
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (where appli-
cable) and the four-phase item flow diagram guidelines were followed[29] (See Fig 1). The
review protocol was registered with PROSPERO (CRD42018070418).
Design
A systematic review was planned to explore two research questions: 1) what is the perception
and provision of routine supervised exercised therapy for PAD, and 2) what are the barriers
and enablers to walking in IC? Given, that the two proposed review questions are tangential to
each other, requiring different search strategies and inclusion criteria, the decision was made
to execute the two research questions in separate reviews for clarity and ease of synthesizing
the findings.
This present paper reports on the barriers and enablers of walking exercise in patients with
IC, and was conducted using the integrative review strategy reported by Whitmore and Knafl
[30]. An integrative review is a specific review approach that summarizes evidence from
research of diverse methodologies (empirical or theoretical literature), and may be used to
frame a more comprehensive understanding of a particular phenomenon or healthcare prob-
lem[31], such as factors influencing IC patients engagement in therapeutic walking. Integrative
review methodology was selected as it is the only approach that would enable a systematic evi-
dence synthesis from both quantitative and qualitative data. Inclusion of both types of data is
desirable in this review to gain a comprehensive understanding of the review topic, and will be
useful to begin to build knowledge about the concept of walking intervention in this population.
The overarching aim of the review is to utilize the understanding of the barriers and enablers to
walking in patients with PAD and IC to conceptualize a patient-centered walking program.
This integrative review entailed a systematic literature search, data extraction, quality
appraisal, and data synthesis via a deductive framework aggregation of findings into concep-
tual units using the Social Cognitive Theory Framework[32]. First proposed by Bandura
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[32,33], social cognitive theory explains how people acquire and maintain certain behavioral
patterns, while also providing the basis for intervention strategies[34]. The use of social cogni-
tive theory has been increasingly identified as a viable framework to implement a review to
guide intervention development for physical activity in chronic conditions[35–37], such as IC.
This review was framed using the social cognitive perspective, as it allowed the examination of
the multiple levels of factors and their influence in walking among patients with IC, providing
insight into important considerations for developing walking interventions.
Study eligibility criteria
Types of participants. Studies reporting on adults (18years) with PAD and IC were eli-
gible. To be included, all study participants must have been specifically diagnosed with IC.
Diagnosis could have been by having Fontaine stage II PAD, or its equivalents, or if it was
stated that only patients with IC were included in the study. Studies with participants having
critical limb ischemia (rest leg pain, ischemic tissue loss, or an ABI<0.4) were excluded.
Types of studies. Quantitative, qualitative and mixed methods studies in English language
literature were eligible if published in peer review journals, or conference proceedings, and
reporting primary data on barriers, enablers, facilitators or motivators for walking exercise
and/or physical activity in IC. In addition to studies which examined the barriers or enablers
for walking (either cross-sectional or longitudinal), studies reporting on experiences of living
with IC were included if they specifically mentioned barriers or motivation or facilitators to
walking. Also eligible were intervention studies that reported on factors influencing walking
outcomes.
Context. Studies with any cultural, healthcare, geographical, or community contexts were
included.
Fig 1. PRISMA flow diagram for systematic review of barriers and enablers to walking in individuals with
intermittent claudication.
https://doi.org/10.1371/journal.pone.0201095.g001
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Identification of primary research studies
A systematic literature search was implemented until January 2018 (updated in June 2018) in
five databases (CINAHL via EBSCO, MEDLINE via ProQuest, AMED via Ovid, Science direct,
Social citation index/ Science citation index /Emerging sources citation index via Web of Sci-
ence) by the first author (UA). The following key words, and medical headings in combination
with database specific search syntax, filters, limiters, and Boolean operators were used: Periph-
eral arterial disease OR Peripheral vascular disease OR Peripheral occlusive disease OR Inter-
mittent claudication OR Claudication pain AND Quality of life, OR Patient reported
experience OR Patient experience OR Illness beliefs OR Factors OR Enablers OR Motivators
OR Barriers OR Facilitators AND Walking OR Walking exercise OR Supervised exercise OR
Physical activity OR Exercise. Further searches were made to identify studies from the refer-
ence lists of relevant studies. A sample search strategy is presented in the supporting
information.
Data management. Studies were exported to remove the duplicates in Refworks™ and
then exported to Microsoft Excel. Two review authors (UA, EE) read the title, and abstract, fol-
lowed by full text to identify eligible studies against the previously defined eligibility criteria.
Studies without a self-report or objective finding on factors related to walking, or studies with-
out a homogenous sample of individuals with IC were excluded. In cases of divergence in anal-
ysis of eligibility decision, studies were discussed until a consensus was reached, or a third
author (CS) was consulted.
Data extraction processes
The data extraction was independently conducted by two review authors (UA, EE), with the
results discussed afterwards to reach a consensus. A customized data extraction form specifi-
cally developed and piloted for this review was utilized. Data forms included author’s details
(author, year, and country), study aim, study design, level of evidence, sample characteristics/
cultural context, variables, results, authors’ main conclusion. When an article was only avail-
able as an abstract email requests for the full length of details of an article were made (up to
twice) to the study author. The article was excluded if there was no response or if the full detail
was not available. The table of characteristics of included studies is presented in Table 1.
Critical appraisal/level of evidence
The methodological quality of the included studies was accessed using the Critical Appraisal
Skills Program (CASP) instrument[56]. Specifically, the CASP Qualitative Checklist, CASP
Randomised Controlled Trial Checklist, or CASP Cohort Study Checklist was selected as
appropriate to appraise studies. CASP is a generic quality appraisal tool providing guidelines
for appraising studies of range of methodological designs, and consists of nine to twelve ques-
tions which are answered with ‘yes’, ‘no’, or ‘can’t tell’. The initial two questions in the CASP
checklist are screening questions related to the study aim and methodology, and have to be
positively answered for the study to meet quality criterial to continue in the evaluation and
review. If a study merits inclusion following a “yes” response to the first two CASP questions,
the level of evidence in the study was subsequently assigned following the Melnyk and Fine-
out-Overholt guidelines[57]. In summary, a study with the highest and most robust level of
evidence (systematic reviews) is assigned Level I, whereas the lowest evidence (from the expert
opinion of authorities and/or reports of expert committees) is given Level VII. Discrepancies
in ratings between authors were resolved by discussions in consultation with the review team.
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Table 1. Table of data extraction and characteristics of included studies.
Author
details, date,
country
Study aim(s) Study design,
Analysis,
Level of evidence
Sample and context Variables Authors main conclusions
Bartelink
et al.[38]
Netherlands
Report factors which
affected walking behavior in
patients with IC
MM
Regressions
analysis
LoE: VI
-Cross sectional study n = 216; 69%
Male
-Focus group n = 9
-Dutch primary care patients.
-Age: 66.9y (range42-97yrs;
-Secondary education (85%);
Pulmonary disease (50%);
Osteoarthritis (47%); Hypertension
(33); Hypercholesterolemia (30%);
Myocardial infarction (20%); Angina
pectoris (22%); Diabetes (17%); Minor
stroke/stroke (9%)
IV: Facilitators & barriers
to walking exercise
DV: Walking exercise
Lack of advice, unspecific
advice, & lack of supervision
were important barriers for
performing walking exercise.
Galea et al.
[39]
Canada
Identify barriers &
facilitators associated with
walking exercise in patients
with IC
Focus group
interview
Content analysis
LoE: VI
N = 15
Diagnosis of IC & ABI<0.9
47%Male
Age (mean = 76.9, range 54-89y)
Mean ABI = 0.67
NA Barriers to walking in patients
with IC included irregular
surfaces, uncertainty about
walking, pain, & need to rest;
Enablers are availability of
resting place, cognitive
strategy, support & SEP
availability.
Galea et al.
[40]
United
Kingdom
Explore patients experiences
of & belief about illness &
walking with IC
Semi-structured
interviews
FA
LoE: VI
n = 19
Age: Mean 66 (range 44–79)y
13 Male
Longstanding IC(2y): 53%
NA Illness & treatment
uncertainties may explain the
low participation in walking in
patients with IC
Gorely et al.
[41]
United
Kingdom
Explore experiences of IC &
thoughts on walking as an
intervention
Focus group
TA
LoE: VI
N = 24; 71%Male;
White British; Age: mean (71y);
Duration of IC: median 17.5, range 3-
18months.
NA Addressing the knowledge gap
& uncertainties around the
disease process & walking is
needed enhance behavior in
patients with IC.
Cavalcante
et al.[42]
Brazil
Investigate
sociodemographic
commodities & clinical
variables barriers to PA
Cross-sectional
Regressions
analysis
LoE: VI
N = 145; Sociodemographic: Age
(65y, 55%); 65%Male; Race(39%,
Non-white); Married status(67%,
Married or living with a partner);
Economic level(36% Low income)
Comorbidities: Hypertension (81%);
Dyslipidemia (72%); Overweight
(60%); Cardiac disease (59%);
Diabetes(41%); Current smoker (24%)
IV: Demographic
variables; Comorbid
conditions
DV: ABI, ICD, ACD.
Patients with IC who are older,
with lower economic status,
diabetes, low ABI and walking
capacity are more likely to
experience barrier to physical
activity.
Harwood
et al.[43]
United
Kingdom
Understand perceptions
including barriers &
facilitators, to SEPs
Qualitative
interview
TA
LoE: VI
Patients who declined, withdrew
from, or completed supervised
exercise program.
N = 25; 56%Male; Age: mean = 71,
range = 44–79
NA More education or time
investment is required at initial
diagnosis to overcome
patients’ barriers to healthy
behavioral changes.
Sharath et al.
[44]
USA
Examine relationship
between pain belief & (each
of) symptom severity,
expectation, & baseline PA
Cross-sectional
Quantitative
analysis
LoE: VI
N = 20; Age: mean69y, IQR 66–75;
BMI: median 28[IQR, 20–30]; 95%
Male; Ethnicity: Caucasian (55%),
African American (40%); High school
education (100%)
ABI: median 0.6; Comorbidities:
COPD (25%), Hypertension (80%),
Hyperlipidemia (60%), Diabetes
(20%).
IV: Pain belief &
perceptions using the
Fear-Avoidance Belief
Questionnaire
DV: Daily PA
Engaging in walking in
patients with IC is positively
related to symptoms severity &
underscore the importance of
considering patients belief
about pain in interventions to
increase walking
(Continued)
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Table 1. (Continued)
Author
details, date,
country
Study aim(s) Study design,
Analysis,
Level of evidence
Sample and context Variables Authors main conclusions
Barbosa et al.
[45]
Brazil
Analyze factors associated
with PA
Cross-sectional
Regression
LoE: VI
N = 150; Age = 64±9; 63%Male;
BMI = 26±4.5; ABI = 0.59±1.54;
Duration since diagnosis8y = 72%;
Low income = 35%; Diabetes = 43%;
Hyperlipidemia = 92%;
Dyslipidemia = 87%; Cardiac
disease = 56%; Currently
smoking = 23%
IV: Barriers to walking
DV: PA
Older adults in neighborhoods
without access to green areas
for walking, & who present
poor walking capacity have
lower PA.
Egberg et al.
[46]
Sweden
Describe experiences of
patients about living with IC
Qualitative
interview
TA
LoE: VI
N = 15; 47%Female; Age = mean(73y),
range(64-81y)
NA Experience of living with IC
depends on how active a
patient is or wants to be, &
underscores the need to
understand this experience in
treating IC
Farah et al.
[47]
Brazil
Predicting walking capacity
using clinical characteristics
& WIQ
Quantitative
non-
experimental
LoE: IV
N = 133; 64.7%Male; Age (mean, 63
±8.8; range, 30-80y); BMI = 26.4±4.6;
ABI = 0.59±0.15; Smoking
history = 84.2%;
Hypertension = 76.7%;
Dyslipidemia = 70.7%;
Diabetes = 38.3%; Coronary artery
disease = 56.4%.
IV: Demographic &
clinical characteristics
DV: ICD, ACD
It is feasible to estimate
walking capacity in patients
with IC using clinical
characteristics & WIQ.
Do¨rentamp at
al.[48]
Netherland
Assess associations of
demographic & clinical
variables during & after SEP
Prospective
cohort
Regression
analysis
LoE: IV
N = 2995; 1864Male; Dutch patients
with IC attending community-based
SET and who have ICD <1600m at
baseline; Age (mean = 67y); Vascular
comorbidity 62%; Internal
comorbidity (54%); Cardiac
comorbidity (49%)
IV: Age, gender, BMI
DV: ICD
Being female, advanced age,
higher BMI, & having a cardiac
comorbidity are associated
with less improvement in ICD
ability after SET in IC patients.
Gardner et al.
[49]
USA
Compare gender variations
baseline clinical variable, &
changes in ambulatory
outcomes due to exercise
training
RCT
Regression
analysis
LoE: II
N = 48;
Patient characteristics (M,F):
ABI(0.66, 0.69)
BMI(28.7, 30.1); Caucasian race(65%,
40%); Smokers (30%, 48);
Hypertension(835, 92%),
Dyslipidemia(74%, 76%), Diabetes
(355, 64%), Obesity(39%, 52%);
Metabolic syndrome(78%, 88%)),
Abdominal obesity(39%, 64%); Lower
extremity revascularization(26%,
35%); Previous history of angina(265,
24%); Cerebral vascular accident(175,
12%); COPD(30%, 36%)
IV: Gender;
DV: Exercise measure &
ambulatory outcomes e.g.
ICD, ACD
As women showed less
improvement in peak walking
distance in an onsite
supervised exercise program,
obese men and patients with
low claudication onset time
were least responsive to the
program
Gardner et al.
[50]
USA
Determine if baseline
variable, AND dose of
ambulation during a HBE
program predict ambulatory
outcomes
RCT
Regression
analysis
LoE: II
N = 46; 22Male; Mean Personal
characteristics: (Age(66, 68y); ABI
(0.71, 0.66); BMI(29.4, 28.3)
Demographic/ Clinical characteristics
(M,F), %:
Caucasian (59, 63); Smoking (23, 42);
Hypertension (86, 92); Dyslipidemia
(82, 88); Diabetes (36, 46); Obesity(41,
41); Abdominal obesity (55, 58);
Metabolic syndrome (82, 92);
Revascularization (27, 50); Angina
(27, 21); CVA (18, 33); COPD (14, 33)
IV: Exercise cadence &
time, Age, Smoking, ABI,
Race, Metabolic
syndrome, COPD,
Revascularization
DV: COT, PWT
While faster ambulatory
cadence may predict greater
improvement in ambulatory
function in women with IC,
less severity and lower
comorbid burden are the
predictors in men.
(Continued)
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Data synthesis
Using the social-cognitive framework[32,33], a deductive framework synthesis approach was
implemented to aggregate findings within conceptual units. We did not set a prior list of what
constituted barriers or enables, but identified these as they were reported in the included stud-
ies. These barriers and enablers were then classified into those related to the individual (per-
sonal), to walking activity (behavioral) or to the environment (environmental). This synthesis
method fitted within the review objective as it provided a highly structured and detailed
approach to analyzing and organizing data from included studies. Two authors (UA, EE)
Table 1. (Continued)
Author
details, date,
country
Study aim(s) Study design,
Analysis,
Level of evidence
Sample and context Variables Authors main conclusions
Fritsch et al.
[51]
USA
To investigate the effect of
smoking on walking ability
Cross-sectional
Descriptive & t-
test
LoE: VI
N = 105; Age: 70±9.1y; 92%Male;
Current smokers: 34%; Race: 80%
Caucacians; Heart disease: 31%;
Diabetes: 65%;
IV: Current smoking
status
DV: ICD, MWD
PAD patients who smoke have
lower ICD compared to those
who do not.
Kruidenier
et al[52]
Netherland
To identify predictors of
walking distance following a
SEP
Prospective non-
experimental
Mann-Whitney
U & χ2 analysis
LoE: VI
N = 129; Male:88; Age:65.6±9.9;
BMI:26.5±4.4; Resting ABI:0.71±0.21;
SBP: 156.7±26.0; Current
smokers:42%; Hypertension: 78%;
Diabetes: 28.%; Pulmonary disease:
17%; Neurological disease: 52%;
Cardiac disease: 34%; Orthopedic
disease: 12%
IV: Clinical
characteristics &baseline
ACD
DV: post treatment ACD
& % change in ACD
Baseline ACD, BMI, and
current smoking status are
predictive of the value of ACD
post-treatment with SET.
Galea et al.
[53]
Canada
To identify psychosocial
determinants of walking
exercise and the mediating
role of pain in the intention-
behavior gap
Prospective non-
experimental
Descriptive,
Correlation &
Regression
analyses
LoE: IV
N = 94; 65%Male; Age = 70.05±9.02;
Ethnicity: White = 94.7%; Marital
status: Married = 65%; Education
level:Secondary = 61%; Smoking
status: Currently smoker = 34%;
Treadmill exercise program
participation: Currently
enrolled = 37%; Disease location:
Unilateral = 59%; Claudication
symptom duration: >2y = 64%;
Pharmacological pain treatment:
Yes = 15%.
IV: Attitude & perception
of walking; Perceived
behavior control; Walking
intentions; Pain intensity.
DV: Walking exercise
While pain cognitions do not
influence walking in patients
with IC, the theory of planned
behavior may be used to
predict walking intentions and
exercise in this patient
population
Aherne et al.
[54]
Ireland
Investigate patients’ exercise
participation & compliance
& factors influencing
patients outcomes
Prospective
Observational
cohort
Descriptive &
Regression
analysis
LoE: IV
N = 98; 82%Male; Age(mean = 69.2
±10.1) Education: 39% had
Secondary education
Current smokers: 37% Chronic
obstructive pulmonary disease: 14%
Ischemic heart disease: 20%
Chronic kidney disease: 7%
Diabetes: 20% Hypertension: 61%
Hypercholesterolemia: 78%
IV: NA
DV: Total number of
exercise session a patient
attended
Improvement in function of
SEP and patients’ compliance
may be gained by pre-exercise
patients’ education and
personalized exercise
prescription.
Cornelis et al.
[55]
Identify barriers to PA &
needs & interest for
technology-based exercise
Cross-sectional
Descriptive &
correlation
LoE: IV
N = 99; 76Male; Mean age: 69y; 81%
Retired; 65% with at least a secondary
education; 53% had bilateral
symptoms; 28% Smokers; 92%
Hyperlipidaemia; 92% Hypertension;
30% Diabetes mellitus;
IV: Barriers to PA
DV: PA levels
Pain & obstacles worsening
pain are the major barriers to
PA in IC.
Key: CA: Content analysis; FA: Framework analysis; IV: Independent variable; DV: Dependent variable; NA: Not applicable; SEP: Supervised exercise program; IHD:
Ischemic heart disease; ICD: Initial claudication distance; ACD: absolute claudication distance; CI: Confidence interval; HBE: Homebased exercise; LoE: Level of
evidence; COPD: Chronic obstructive pulmonary disease; TA: Thematic analysis.
https://doi.org/10.1371/journal.pone.0201095.t001
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independently undertook coding of findings, and mapping of barriers and enablers to the
framework. The synthesis decisions were reviewed by the authors until consensus was reached.
Results
Study selection
The process of identifying, screening, and studies inclusion is summarized in a PRISMA flow
chart (See Fig 1).
Characteristics of included studies
Eighteen studies, consisting of quantitative (n = 12)[42,44,45,47–54], qualitative (n = 5)[39–
41,43,46] and mixed method (n = 1)[38] designs, and involving a total of 3023 participants
with IC, were included in the final review. Study participants ranged from 15[39][46] to 1741
[48]. Included studies were from a total of eight countries with most from the USA (n = 4), fol-
lowed by Brazil (n = 3), Netherland (n = 3), United Kingdom (n = 3), Canada (n = 2), Republic
of Ireland (n = 1), Belgium (n = 1), and Sweden (n = 1)(Table 1). Most of the included studies
(n = 10)[38,39,43,46–48,50,52,54,55] did not report data on the ethnic background of partici-
pants. Where reported, all studies (n = 8) had a majority of white participants[40–42,44,49–
51,53]. Participants’ educational background was not reported in the majority (n = 13) of the
included studies [39,40,43,44,46–52,58]. Where reported, most of the participants had com-
pleted at least either primary[38,42,54], or secondary[53][55] education. Only one study
reported participants’ income status with most participants of high income[42]. Only two
studies had data on participants’ marital status with the majority of the participants married or
living with a partner[42,53]. Most (2815; 64%) of the participants in the included studies were
male. Participants’ age in included studies ranged between 30–97 years. Although the disease
duration, severity and comorbid burden varied between studies, all the included studies com-
prised only participants with a confirmed diagnosis of symptomatic PAD defined as IC.
Where reported, the mean/median resting ABI reported ranged from 0.59[42,45,47,52] to 0.71
[50,52], while disease duration since diagnosis ranged from newly diagnosed [40,53] to over
two years[40,53].
Quality of evidence/level of evidence
All eighteen studies were rated based on the CASP criteria. On the Melnyk and Fine-Overholt
evidence hierarchy [57] evidence level in included studies ranged Level VI (n = 11), Level IV
(n = 5), to Level II (n = 2). Although the majority of the studies were qualitative and non-
experimental and the level of level of evidence was mostly moderate to low, these types of stud-
ies fitted within the review objective, and were included in the review.
Barriers to walking exercise
The number of studies reporting on different dimensions of barriers to walking is illustrated in
Fig 2.
Person related barriers. Comorbid health factors: Comorbid health concerns were the
most frequently identified barriers among participants. These barriers were reported by four
(80%) of the qualitative studies[39–41,43] and were examined by nine (75%) of the quantita-
tive studies[42,44,45,47–50,52,55] and the mixed method study[38]. Participants across the
qualitative and mixed methods studies cited preexisting medical conditions and comorbidity
as barrier to engaging in walking exercise[38–41], or dropping-out from a SEP program[43].
The nine quantitative studies examined baseline factors associated with engaging in walking
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exercise and physical activity[42,45,47] or predictors of walking outcomes following SEP inter-
vention[48–50,52]. Barbosa et al. reported that comorbid health conditions were a prevalent
barrier to physical activity in 77 (51%) of their participants[45]. Diabetes was associated with
decreased physical activity[45], lack of physical energy, personal barriers to physical activity
[42], and was a predictor of poorer pain-free and maximum walking distances[47]. Similarly,
higher BMI independently predicted lower improvement in pain-free[48] and maximum
walking distance[52], and obesity predicted lower physical activity levels[45], and poorer
improvement in both pain-free and maximum walking distance in men with IC[49]. Other
comorbid conditions reported as barriers to physical activity included hypertension, arthritis,
angina[45], and metabolic syndrome[45][50]. Participants across several studies also reported
avoiding walking exercise or physical activity due to fear of falling, fatigue, injury or other
adverse health issues[40–42,44,45,55].
Low walking capacity (walking capacity is the distance or length of time patients with IC
can walk before pain symptoms are felt, or the pain experienced causes them to stop walking):
Participants in one qualitative study reported that low walking capacity prevented them from
moving around[46]. Seven quantitative studies examined the association between participants’
walking capacity measures and physical activity, or the role of participants’ walking capacity in
mediating walking outcomes following SEP. These studies all indicated that low walking
capacity was associated with lower physical activity[42,45,47], and lower pain-free and maxi-
mum walking distances following SEP, especially in women[49,50,52]. Also a lack of physical
energy or inability to exercise at appropriate level was associated with decreased in walking
exercise engagement[45][54].
Lower ABI: Two quantitative studies reported lower ABI as a barrier. Low ABI was associ-
ated with “some difficulty in getting to a place where physical activity can be performed”[42].
Similarly, poorer ABI predicted poorer improvement in 6-minutes walking distance of partici-
pants after a home-based exercise program[50]
Age: Participants in one qualitative study cited age as a barrier[41]. Three quantitative stud-
ies reported older age (>65 years) was a barrier to more physical activity engagement[42], and
was associated with lower physical activity[45], or poorer improvement in pain free walking
distance after SEPs[48].
Fig 2. Barriers to walking in individuals with intermittent claudication and number of studies which reported
them.
https://doi.org/10.1371/journal.pone.0201095.g002
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Female gender: Three quantitative studies examined the influence of gender in ambulatory
outcomes during and/ or after SEP. These studies showed that being female was associated
with relative poorer improvement in pain free walking distance[48,49]. Also a lower mean
exercise cadence predicted poorer pain free and maximal walking distances only in female par-
ticipants[50].
Current smoking history: Three quantitative studies examined current smoking history as
factors influencing walking ability or walking exercise engagement. Current smokers had
lower pain-free walking distance than non-smokers[51]. Current smoking also predicted
lower maximal walking distance following an exercise program[52]. Finally, current smokers
had a lower mean attendance at exercise sessions compared with non-active smokers[54].
Lack of knowledge: Three major themes relating to lack of knowledge as a barrier to walk-
ing exercise were identified by the qualitative studies. The first theme was that participants did
not engage in walking exercise because they lacked understanding of the pathology of IC
[40,41]. The second theme was the lack of understanding and uncertainty regarding walking
guidelines or suitable therapeutic walking dosages[41]. The third theme was that participants
did not understand, or were uncertain, regarding the benefit of walking exercises, and how
risk factors work[39–41,45,55]. Similar to this was participants’ outright disregard of walking
as a treatment for IC[40]: “There’s no treatment. I’m getting no treatment, not for this. I’m get-
ting advice, and the advice is ‘try to walk through it’. That’s the only advice I’ve ever had”[40].
Incidentally, the quantitative studies found that lack of knowledge was associated with low
education level[42], and also that it predicted walking intention[53].
Perceived lack of improvement: One mixed methods study[38] and two qualitative studies
[40,41] reported perceived lack of symptom improvement or lack of confidence that walking
was providing any benefit as a barrier to walking exercise. Also, one quantitative study
reported that subjective feelings of supervised training not providing any benefit was a barrier
to participants continued attendance at SEPs[54].
Lack of time: The barrier of lack of time was identified in two quantities and three qualita-
tive studies. Reasons for lack of time included associated burden of a hospital-based SEP
[40,43], having other responsibilities such as caring for the grandchildren or elderly relative
[43], and the need to “plan walking activity to avoid hills and allow greater time”[41]. Partici-
pants in two studies however, were not specific and stated generally perceived time constraints
[39,45].
Other personal barriers: Other barriers reported included not having many symptoms gen-
erally or following invasive therapy[38], lower socioeconomic status[42,45], “feeling of isola-
tion, and dependence, missing previous life and conforming to restricted life”[46].
Walking activity related barriers. Walking induced pain: Walking-related claudication
pain limitation was the most frequently identified behavioral barrier. Ten studies representing
the only mixed method design[38], all (100%) of the qualitative[38–41,46], and four (33%) of
the quantitative studies[42,45,53,55] reported pain related to walking as a barrier. Participants
in the qualitative and mixed method studies commonly cited leg pain, discomfort or the need
for frequent stops due to leg pain as a barrier to engaging in walking exercise or walking to a
therapeutic intensity. Barbosa et al[45], a quantitative study, investigated the prevalence and
predictors of barriers to physical activity, and showed that exercise-induced pain was the most
frequently reported personal barrier. Also the need to rest because of pain predicted lower
physical activity[45]. Another quantitative study[42], which investigated the relationship
between barriers to physical activity and the sociodemographic and clinical characteristics of
the participants identified needing to rest due to pain as a barrier. The third quantitative study
investigated mediators of walking exercise and reported that people who experience bilateral
claudication pain had weaker intention to walk than those with unilateral pain[53]. The fourth
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quantitative study[55] investigated barriers to PA and reported walking limiting pain as the
most important barriers among participants.
Fatigue: Two quantitative studies reported fatigue (also described as “lack of physical
energy”) as a significantly prevalent barrier[42,45] that was associated with declining physical
activity[45] among participants. Similarly, participants in one qualitative study[39] indicated
that they do not engage in walking exercise due to fatigue and low energy levels.
Lack of motivation: Lack of self-motivation to exercise (also described as “lack of confi-
dence” “lack of conscientiousness” or “lack of interest” by researchers) was another behavioral
barrier frequently identified among participants in qualitative[39–41], and mixed method
studies[38]. Also, one quantitative study[54] showed that lack of interest in exercise was the
second most frequent reason given by participants for non-attendance in a community-based
SEP.
No walking advice or lack of specific walking advice: Two qualitative studies[40,41] and
one mixed method study[38] reported barriers related to receiving advice; two major themes
emerged from these studies. The first theme was that participants did not engage in walking
exercise because they did not receive instruction to walk from the health professionals[38].
The second theme was that the instructions given by the health professionals were neither spe-
cific, tailored, purposeful nor accompanied with any walking plan[38,40,41]. Interestingly,
lack of advice or lack of specific advice as a barrier to walking exercise was not examined as a
potential barrier in any of the included quantitative studies.
Lack of supervision: One mixed method study noted lack of supervision during walking
exercise was a barrier to continuing in walking exercise[38]. Lack of monitoring during physi-
cal activity was reported as a prevalent barrier in one of the quantitative studies[45]. No quali-
tative study investigated lack of supervision as a barrier to engaging in walking exercise/
physical activity.
Environment related barriers. Adverse weather conditions: Inclement weather was the
most frequently identified environmental barrier. Unfavorable weather/season (e.g. winter)
emerged as a barrier to walking exercise among participants in two qualitative[39,41] and one
mixed method studies[38]. Also two quantitative studies[42,45] reported unfavorable weather
as a barrier to participants engagement in physical activity.
Lack of/poor walking surface/obstacles that worsen pain: Absence of, uneven or poorly
maintained pavements, or the presence of slopes or stairs were cited as barriers to walking
[41,42,45,46]. Also, the presence of obstacles that exacerbated leg pain and not having a place
to rest/sit when experiencing leg pain were reported as barriers associated with lower physical
activity[42,45,55].
Lack of green areas/neighborhood/local facilities to engage in physical activity: Two quanti-
tative studies reported lack of green areas, or not having facilities including SEP centers as a
barrier to engage in walking exercise[42,45]. Similarly, participants in one study indicated
security concerns and concern posed by vehicle movements as barrier to engaging in physical
activity[45].
Enablers to walking exercise
Enablers to walking exercises and the number of studies which reported on them are presented
in Fig 3.
Person related motivators. Belief that walking exercise could be beneficial: Belief about
the potential benefit of walking was reported as enabler in two qualitative studies[40,41], and
one mixed method[38] study. Participants indicated that their belief that walking could
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improve, slow down the deterioration of symptoms, and or potentially replace higher risk
interventions, motivated them to engage in walking exercise.
Perceived improvement: Two themes related to participants’ perceived improvement as a
motivator emerged from one qualitative[41] and one mixed method[38] study. The first theme
was that participants belief in potential improvement or perceived improvement in general
health motivated them to continue walking exercise[38]. The second was that participants’ per-
ceived improvement in claudication symptom motivated them to continue walking exercise
[38,41].
Other motivators: Other personal motivators identified include good understanding about
IC, family history of serious vascular disease like amputation acting as warning[38], history of
ischemic heart disease or hypercholesterolemia[54], and good baseline maximal walking dis-
tance[52].
Walking behavior related motivators. Walking advice: Themes related to walking-
related advice as a motivator to walking were reported in three studies. Receiving advice was
the most important determinant of patients undertaking walking exercise[38]. Further, partici-
pants indicated that their desire to follow the walking advice provided by the health profes-
sionals motivated them to engage in walking exercise[38]. Also, participants in two qualitative
studies indicated that a specific, purposeful, and tailored instruction about walking was a moti-
vator to them to engage in walking[40,41].
Using cognitive strategies: Cognitive strategies as a motivator was identified in three quali-
tative studies and three subthemes were described. The first subtheme was related to planning
walking into daily life[40]. The second subtheme was that objective walking goal setting
enabled participants to actually undertake walking [46]. The third subtheme was that partici-
pants were able to continue to walk in spite of pain using mental (e.g. positive self-talks) and
behavioral (e.g. stopping to take breaks) pain-coping strategies[39]. Similar to the cognitive
strategies, two studies reported that participants’ perceived behavioral control[53], and having
the intention to walk[39] were strong motivators for them undertaking walking.
Environmental related motivators. Support system: Two qualitative and one mixed
method study reported three subthemes describing support systems as a motivator to engaging
in walking exercise. The first subtheme was the social and emotional support, including com-
panionship, provided by family members and animal pets[38,39,46]. The second subtheme
was the group members’ support systems (derived from e.g. a group exercise program or
Fig 3. Enablers to walking in individuals with intermittent claudication and number of studies which reported
them.
https://doi.org/10.1371/journal.pone.0201095.g003
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patient support groups)[38,39,46]. The third subtheme was the encouragement and support
given by the health and social care professionals[39,40,46].
Availability of SEP: Availability of supervised exercise program was identified as a motiva-
tor to engaging in walking in two qualitative studies[39,40].
Others: Other environment related motivators identified include supervision and/or some
form of monitoring[40], and having place to rest when having leg pain[46]
Discussion
This integrative review allowed the use of a social cognitive theory framework to categorize lit-
erature about barriers and enablers to walking activities in individuals with PAD and IC. It
also provides a conceptual framework to develop a self-management program to enhance
uptake and adherence to walking in this population. A broad range of personal, walking activ-
ity related and environmental barriers and enablers that influence walking exercise were iden-
tified. Although the majority of included studies were descriptive and qualitative studies, the
study designs were appropriate for the review objective which focused on the identification of
barriers and enablers rather than on the impact of a specific intervention or the evaluation of
impact.
Personal (as opposed to environmental) factors were the mostly frequently explored barri-
ers in the included studies. At the personal level, review findings highlighted comorbid health
concerns, low walking capacity, and lack of knowledge (e.g. disease understanding) as the
most common barriers to walking. Walking limiting pain or fatigue symptoms and lack of
motivation were the most frequently reported walking activity related barriers. Similarly, the
most frequently identified environmental barriers were adverse weather, and poor walking
surfaces presenting obstacles that worsen pain. In contrast, benefits from cognitive strategies
(such as prior planning of walking, goal setting and behavioral pain-coping strategies), and
support systems (such as family, patient group, and healthcare environment that provided
social, emotion and information support) were the most reported walking related and environ-
mental enablers, respectively. Also, the perception of walking as either having potential or
actual benefit was the most common personal enabler for individuals to engage or continue
with walking.
The identified barriers and enablers in this review give insight into important consider-
ations for planning walking interventions, and also provide information on specific factors
that may assist in overcoming anticipated barriers. First, individuals with IC present with high
prevalence of comorbidities, reduced walking capacity, and typically lack understanding of
their disease pathology, risk factors and the benefit of walking[53,54]. Although several comor-
bid conditions may prevent individuals with IC from participating in a standard SEP, exercise
is essential to reduce the impact of many of these comorbidities (e.g. hypertension, diabetes,
advanced age, obesity, metabolic syndrome), reported as barriers in the included studies
[38,40,43,46,58–60]. With some tailoring around specific walking advice, individuals’ specific
characteristics, including barriers due to concerns about comorbidities may be addressed. An
important aspect of tailoring might be starting on a lower walking regime commensurate to
their walking capacity. For instance, as a preparation to the recommended 3x 30–60 minutes
of walking exercise beyond the point of pain, advice may be tailored to patients to undertaking
more frequent walks up to the point of exhaustion or the onset of pain, whichever comes first.
This way exercise dose will be gradually increased as a progression towards the recommended
level. Also, individuals should be educated on the benefits of walking exercise as a component
of risk factor management beyond IC symptom improvement. Indeed, an individual’s percep-
tion of walking as having potential or actual benefit from walking is the most common
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personal enabler to engage in or continue walking in spite of pain. Individuals who opt to
undergo a home-based exercise program should also receive the education and should be sup-
ported with some form of supervision as encouragement to engage in walking. The use of exer-
cise diary, follow up calls, goal-setting and self-feedback using a pedometer are some of the
ways to do this within a home-based exercise program.
In addition to the personal barriers, walking limiting pain or fatigue is characteristically
unique to individuals with IC. Individuals with IC only experience pain after they have been
walking, and which gets better with rest. This suggests that an approach to pain management
which considers both the intermittent nature of the pain and fatigue, and its association with
walking (the behavior of interest being prevented) may be a uniquely important consideration.
For this reason, previous systematic reviews have explored alternative strategies towards pain
management during exercise, for example, recommending exercising more frequently at
threshold of mild pain[61], or the need to investigate alternative forms and prescriptions of
exercise other than walking (e.g. polestriding, leg and arm ergometry, and resistance exercise
[62,63]. In addition to those recommendations, pain barriers could potentially be addressed by
a suitably structured walking program, pain management and patient education based on
behavioral change techniques (cognitive strategies). By deferring the onset of pain and provid-
ing motivation to walk through structured patient education, individuals may be able reach
the recommended walking guidance for therapeutic benefit.
Both physical and social environmental factors were identified as impacting on walking in
individuals with IC. Again, while many of these environmental factors are common to the gen-
eral population, some were unique to individuals with IC. For instance while the availability
and accessibility of SEPs to individuals with IC may encourage more individuals to participate
[39,40], removing physical barriers, like lack of green area, security concerns, lack of/poor
pavements, and lack of local facility for walking may further encourage them to translate this
to walking in the community. Some other factors such as uneven or poor walking surface, and
stairs might present an unequal demand on the lower limb muscle of individuals with IC, mak-
ing pain come on more quickly. Similarly, the reluctance to engage in walking due to fear of
not having a place to rest when experiencing leg pain may be greater in individuals with IC.
Beyond the policy implications for the physical environment, these findings highlight the
importance of considering how walking programs for these individuals may be tailored to
overcome these barriers.
Other environmental factors, such as the social environment, gave credence to the role of
the family, healthcare and social support systems in influencing walking exercise in this popu-
lation. Specifically, IC individuals emphasized benefit of having a walking partner[38,39,46],
encouragement from health professionals[39,40,46], and the value of patient support groups
[38,39,46]. Whether it is a SEP, home-based exercise walking program, or alternative exercise
program, the potential benefits that these support systems may provide should be harnessed to
enhance individuals’ engagement and adherence to the exercise.
Implication for designing walking exercise interventions for individuals
with IC
Walking limitations in individuals with IC impact physical function, social participation, qual-
ity of life and overall disease outcome[1,2] [4] [3]. Inactivity in this population accelerates dis-
ease progression and accentuates the risk of cardiovascular events[4] [3]. The findings from
this review highlights the factors and constructs, within a social cognitive framework, enabling
a comprehensive understanding of what makes patients’ engagement with, and adherence to,
walking difficult. This has important implications. Personal, behavioral and environmental
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barriers may need to be addressed to promote and sustain adoption of walking exercise, either
in SEPs or home-based exercise programs. Addressing comorbid health issues with patient
education and appropriate exercise tailoring may benefit a larger proportion of patients, who
often have comorbid health conditions. Similarly, a pain management strategy that prolongs
time before pain becomes unbearable may, not only encourage patients to engage in walking,
but may also prolong the time to reach pain tolerance, enabling them gain the maximum ther-
apeutic benefit from walking. Finally, with a good support system (provided by health profes-
sionals, patient groups and relatives) and an intervention tailored with the understanding of
patient physical environments, it is possible that patients will be encouraged to form healthy
exercise habits. One possible consideration is how structured education, delivered alongside
patient-centered pain management with or without SEP, may be used to boost walking exer-
cise engagement and adherence in individuals with PAD and IC. The MRC guideline for com-
plex intervention development[64] provides a framework for the development of such
interventions. An important next step to developing such an intervention would be the identi-
fication of the useful components of pain management and patient education, which may need
to be accomplished through systematic literature reviews.
Limitations
This review has several limitations. First, it was based only on English language peer review lit-
erature of published research. Other relevant studies published in different languages may be
available. Secondly, it is acknowledged that the demographic and disease characteristics of par-
ticipants varied across included studies, potentially impacting on what influenced walking
behavior. To account for these variations, attempts were made to identify factors within, but
not limited to, the framework. Nevertheless, other than identifying patients’ characteristics as a
barrier and/or enabler, conclusions specific to these characteristics within the heterogeneous
group of patients with IC could not be drawn. Thirdly, the majority of the included studies
were qualitative and non-experimental designs, therefore, identification of causal factors
responsible for walking (or not walking) was lacking. In addition, only two of the included
studies implemented randomization in sample group allocation, limiting generalization to
sample populations. However, the type and quality of studies included in this review were con-
sidered adequate and fit the review objective which was to identify factors, rather than estab-
lishing causal and effect relationship these factors or of an intervention. Finally, another
limitation of this review is the preliminary nature of the proposed framework within this topic.
However, a relatively large number of studies were included, and given that this is the first
review on factors influencing walking specific to individuals with IC from PAD the findings
contribute to a comprehensive and deeper understanding of walking exercise in this patient
population.
Conclusion
The common barriers to walking exercise among patients with IC are comorbid health con-
cerns, walking limiting pain, and lack of motivation. Patients’ poor understanding of the dis-
ease and lack of clear walking advice encourages the belief that walking is harmful. Patients
need encouragement, support and feedback to engage and adhere to walking exercise recom-
mendations. The review findings indicate that patients have different barriers and enablers
indicating that a one-size-fits-all walking exercise programs may not be a solution for all eligi-
ble patients with IC. Therefore, practice needs to adopt a patient-centered approach, particu-
larly addressing disease understanding, via patient education, and walking limiting pain to
overcome barriers and increase walking exercise engagement and adherence among patients
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with IC. Similarly, future research that explores the useful components of pain management
and patient education interventions and how these can be used to develop targeted patient-
centered walking interventions in patients with IC is essential.
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